Arca Biopharma | ABIO - Gewinn Vor Steuern

Aktienkurs
61.10
Täglich Wechseln
1.52 2.55%
Monatlich
46.35%
Jährlich
650.61%
Q2 Prognose
57.95




Gewinn Vor Steuern Veränderung Datum
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Amgen USD 3.92B 2.35B 2025-09
Arca Biopharma USD -29.58M 694K 2025-12
Biogen USD 557.3M 186.7M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
CSL USD 2.61B 1.21B 2025-12
Cytokinetics USD -183.03M 123.15M 2025-12
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
Laboratory Of America USD 337M 32.3M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Otsuka Holdings JPY 75.26B 91.16B 2025-12
Pfizer USD 3.33B 290M 2025-09
United Therapeutics USD 444M 6M 2025-12